COMMUNITY ENGAGEMENT CRITICAL FOR ENDING THE HIV EPIDEMIC –  Lessons from breakfast session with community advocates.   – Alaka Oluwatosin

COMMUNITY ENGAGEMENT CRITICAL FOR ENDING THE HIV EPIDEMIC –  Lessons from breakfast session with community advocates.   – Alaka Oluwatosin

There has been lots of changes in the HIV prevention and treatment field over the last 35 years. We have the tools to end the HIV epidemic. However, having the tools to do something is not the same as doing it. These tools are not equitably accessible around the globe hence disparities persist in terms of access to HIV prevention, diagnosis and treatment tools.  

 

Loosely defined, community engagement is the process of working collaboratively with and through groups of people with diverse characteristics who are linked by common ties, social interaction or geographical location (Centers for Disease Control and Prevention, 1997). The success in the battle against the HIV epidemic will require the sustained engagement and unique inputs from various communities inclusive of small informal groups at the grass-roots level up to global coalitions.

 

Nothing has happened in the fight against the HIV epidemic where the community has not been a driving force. Our role as community advocates is the very important to the failure or success of HIV control. Community educators have diverse roles and responsibilities including raising the level of awareness about HIV prevention and treatment in the community. Science matters at the community level and it is critical that communities are represented in order to influence science.

 

If science alone would have gotten us to the end of the epidemic, we would be there. It is important to us as community advocates to fight for our rightful seat at these table to influence the decision making process in the interest of the community we serve; and continue to communicate the importance of the partnership and collaboration between science and community.

 

Going by the experience of Phil Wilson, founder and CEO of the black AIDS institute, there needs to be more synergy between biomedical HIV prevention and treatment and behavior. He stated and I quote “I look at those pills and I notice something every morning: none of those pills have the ability to get into my body without my assistance. What the pills do is biomedical, what I do is behavioral. The pills don’t work unless they are in that marriage between behavior and biology” Clearly, when communities understand the science, they are more likely to protect themselves and engage in treatment (therapeutic or preventive) and it would be easier for them to adhere to treatment as well.

– Alaka Oluwatosin 
 
IMPACT OF PrEP ON HIV INCIDENCE – Lessons from CROI 2018 – Alaka Oluwatosin

IMPACT OF PrEP ON HIV INCIDENCE – Lessons from CROI 2018 – Alaka Oluwatosin

Pre-exposure prophylaxis is for people at ongoing substantial risk to HIV acquisition.  Increased access to people at high risk for HIV infection will have an additional effect. These individuals take HIV medicines daily to lower their chances of getting infected. PrEP can stop HIV from establishing itself and spreading throughout the body. It is highly effective for preventing HIV only when used as prescribed. It is much less effective when its usage is not adhered to. 
While PrEP is effective when used, the ability to use PrEP is enhanced when supported with other intervention measures such as harm reduction strategies for people who inject drugs, mental health service support for people who require this, access to regular HIV testing services, and empowerment programmes for adolescents and female sex workers. Without these support, the effectiveness of PrEP reaching a population impact would be limited in high HIV prevalence countries. 
At the currently assumed PrEP coverage level, 1%-7% of new HIV infections could be averted by year. If coverage was 100% in these populations, between 20%-30% of new infections could be averted.

 

PrEP access requires that health service infrastructures need to be in place to prevent PrEP use without medical health checks. Before starting PrEP, HIV and renal function tests should be carried out while the potential user is given information on the importance of adherence. It is also critical that the individual is monitored throughout the period of PrEP use.  

– Alaka Oluwatosin
ENDING THE HIV EPIDEMIC: THE ROLE OF MENTAL HEALTH – Lessons from CROI 2018 – Alaka Oluwatosin

ENDING THE HIV EPIDEMIC: THE ROLE OF MENTAL HEALTH – Lessons from CROI 2018 – Alaka Oluwatosin

A major cause of death for people living with well treated HIV under the age of 50 is suicide and not the virus itself. This goes to show the critical role of mental health in the fight against the epidemic. People living with HIV have significantly higher risk of developing mental health disorders. If not addressed, we are unlikely to achieve the 90-90-90 goals or ultimately end the epidemic. The speaker, Dr. Robert H. Remien, a Professor of Clinical Psychology in Columbia University, identified mental health to be a risk factor of HIV infection stating that it contributes to 4-10 times increased risk of acquiring HIV.

 

In the context of PrEP implementation, depression is associated with higher sexual risk behavior and poor adherence thus indicating that screening and treatment for mental health problems would be important to maximize the efficacy of PrEP.

 

Although HIV stigma may not be as glaring as it used to be in the early days of its discovery, its impact is still quite strong today though it manifests subtly with very harmful effects. Unfortunately, the mental health related stigma occur at multiple levels – patients, health care workers and policy makers.
Mental health stigma is often coupled with HIV stigma for people living with HIV. Depression is the most prevalent mental health condition in HIV. Studies have shown that women on ART with depressive symptoms are 2-3 more times the risk of mortality compared to women without depressive symptoms when on ART. Hence, while ART is most certainly protective, depression doubles the risk of mortality.

 

In addition to depression, other psychiatric problems such as anxiety disorder, alcohol and other substance use disorder and Post traumatic stress disorders are associated with living with HIV.
Mental health impairment may lead to increased risk behavior, delayed (or lack of) HIV testing and care initiation, poor retention in care, delayed ART initiation and poor adherence. It is clear that mental health problems need to be addressed in order to improve HIV prevention and care related health outcomes. 
Majority of people with mental health disorders across the globe do not receive care because of the exiting gap in access to mental health treatment in general. There is a shortage in human resource, lack of capacity for implementation and poor mental health related policy in place in many countries for many programmes. 

 

As a way forward and an opportunity for intervention, Dr Remien proposed metal health screening across the spectrum of the HIV continuum: when accessing STI testing, at the point of offering and implementation of PrEP, when testing for HIV, when reporting a HIV positive diagnosis, and at the point of ART initiation. This would enhance the detection of mental health problems on time, mitigate its effect on HIV treatment and care, improve adherence to treatment, increase viral load suppression, improve health outcomes for the individual, and ultimately reduce ongoing HIV transmission.

– Alaka Oluwatosin
 ADVANCES IN HIV PREVENTION: Lessons from CROI 2018 – Alaka Oluwatosin

 ADVANCES IN HIV PREVENTION: Lessons from CROI 2018 – Alaka Oluwatosin

Professor Wafaa M. El-sadir from Columbia University gave a snapshot of the world of HIV prevention where she talked about the 3Ts (Trials, Travails and Triumphs) in the field. Over the past decades there has been an amazing evolution in the HIV epidemic from initially a deadly disease if not treated to now a chronic manageable condition with millions of people around the world living a healthy and productive life with HIV. which is a remarkable achievement in the HIV response.

There has been a remarkable progress over the past decades with prevention of new HIV infections. In 2017, there was 1.8 million new HIV infections. Despite the remarkable progress, it is highly unlikely that the world would be able to reach the goal of less than half a million new infections per year by 2020. This should compel us to think about how we can do better in terms of preventing new HIV infections.  This will include how we can better use the HIV prevention tools we have: antiretroviral therapy, prevention of horizontal transmission of HIV, and topical and systemic pre-exposure prophylaxis.  

Prof. Wafaa noted that there is a wealth of evidence that supports that ART + Viral suppression = prevention of HIV transmission. Some studies also show that prevention of new HIV infection in the population can be achieved by scaling up of ART prevention. Preventing new HIV infection in the population will require we identify everyone in the population, getting them tested, identify people who are HIV positive, place them on treatment by linking them to ART services, and secure and maintained the required support to enable people stay virally suppressed. Equal attention should be devoted to all the different stages of the HIV care continuum if we are to achieve our goal in decreasing the number of new HIV infections.

Several studies also shown that PrEP is highly protective but poor adherence is a risk factor for HIV acquisition while on PrEP with the impact worse for women. This had ignited interest in developing in long acting agents for HIV prevention such as the broadly neutralizing antibodies, long acting injectable ARVs, multipurpose rings as well as implants.

We are currently in the global era where combination and integrated services is critical to achieve the needed impact on new infections control.  All HIV management interventions proven effective need to integrated into a combination of HIV prevention strategies to achieve effectiveness. Without doing this, we will fail to achieve the potential of whatever new we discover. We also need precision intervention by learning about WHERE to focus (geographic area), WHO to focus on (specific population), HOW to focus (models of prevention) and also WHAT type of tools we would use for the identified population(s).

  • Alaka Oluwatosin
RESEARCH ADMINISTRATION: A BOTTLE NECK FOR RESEARCHERS WORKING IN SUB-SAHARAN AFRICA –Lessons from Breakfast session with community advocates – Alaka Oluwatosin

RESEARCH ADMINISTRATION: A BOTTLE NECK FOR RESEARCHERS WORKING IN SUB-SAHARAN AFRICA –Lessons from Breakfast session with community advocates – Alaka Oluwatosin

RESEARCH ADMINISTRATION: A BOTTLE NECK FOR RESEARCHERS WORKING IN SUB-SAHARAN AFRICA –Lessons from Breakfast session with community advocates
The CROI community advocates were privileged to have in our midst Dr. Elizabeth Bukusi of the Kenya Medical Research Institute, Nairobi, Kenya who spoke about some of the challenges faced by researchers in sub Saharan Africa. Research Administration ideally should oversee all aspects of the grant management cycle. We don’t have strong management systems. Although we talk about issues of corruption, the systems are not robust enough to be able to manage research funds as we would want them; hence funds are being managed largely from the West.

 

There is a need to strengthen research administration through infrastructural, organizational, and human resource development to match the dynamic research environment and funding requirements. If we don’t address that capacity gap, it makes it difficult to grow the research to fit into our specific needs. It was also identified that another issue we face is in infrastructural development. Facilities, resources and related services that are used by the scientific community are critical to conduct top-level research, without which, we will not be able to do the quality science that we desire.

 

The speaker pointed to the fact that although she has interacted with University of Washington for over 20 years, each time she goes back, she always has to use a map because things have changed with new and better buildings evolving containing better research laboratories and equipments. Whereas, in the university where she studied, she can easily get around because very little has changed. If our infrastructure isn’t developed, it is going to be difficult for us to produce world class scientists. Advocacy plays a very important part.
 As advocates, our voices need to be heard in order to influence decisions within political, economic, and social systems and institutions.

-Alaka Oluwatosin  NHVMAS